Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTSO Cytosorbents Corporation

交易中 12-16 09:50:34 EST

0.6286

+0.0025

+0.40%

最高0.6409	最低0.6276	成交量1.11万
今开0.6409	昨收0.6261	日振幅2.12%
总市值3,948万	流通市值3,456万	总股本6,280万
成交额6,984	换手率0.02%	流通股本5,498万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTSO","market":"US","secType":"STK","nameCN":"Cytosorbents Corporation","latestPrice":0.6286,"timestamp":1765896278853,"preClose":0.6261,"halted":0,"volume":11079,"delay":0,"floatShares":54981813,"shares":62804305,"eps":-0.17054,"marketStatus":"交易中","change":0.0025,"latestTime":"12-16 09:50:34 EST","open":0.6409,"high":0.6409,"low":0.6276,"amount":6984.13689864,"amplitude":0.021243,"askPrice":0.6299,"askSize":200,"bidPrice":0.6202,"bidSize":200,"shortable":0,"etf":0,"ttmEps":-0.17054,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1765918800000},"marketStatusCode":2,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":0.6261,"preHourTrading":{"tag":"盘前","latestPrice":0.649,"preClose":0.6261,"latestTime":"09:25 EST","volume":54,"amount":35.046,"timestamp":1765895113263},"postHourTrading":{"tag":"盘后","latestPrice":0.6261,"preClose":0.6261,"latestTime":"19:57 EST","volume":3,"amount":1.8602,"timestamp":1765846659376},"volumeRatio":1.176738,"impliedVol":1.3682,"impliedVolPercentile":0.376},"requestUrl":"/m/hq/s/CTSO","defaultTab":"news","newsList":[{"id":"2585169426","title":"Cytosorbents Corporation盘中异动 股价大跌6.07%报0.600美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585169426","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585169426?lang=zh_cn&edition=full","pubTime":"2025-11-20 22:55","pubTimestamp":1763650507,"startTime":"0","endTime":"0","summary":"北京时间2025年11月20日22时55分，Cytosorbents Corporation股票出现异动，股价快速下跌6.07%。截至发稿，该股报0.600美元/股，成交量1489股，换手率0.00%，振幅1.80%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.12%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511202255079510d02b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511202255079510d02b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"1129248663","title":"CytoSorbents第三季度营收为948.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1129248663","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129248663?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:46","pubTimestamp":1763574400,"startTime":"0","endTime":"0","summary":"11月13日 - Cytosorbents第三季度每股盈余为-0.05美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"1168256572","title":"Cytosorbents 第三季度营收为 948.5 万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1168256572","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168256572?lang=zh_cn&edition=full","pubTime":"2025-11-14 05:25","pubTimestamp":1763069128,"startTime":"0","endTime":"0","summary":"11月13日消息 - Cytosorbents 第三季度每股收益为 -0.05 美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2582765339","title":"Cytosorbents Corporation盘中异动 股价大涨5.85%","url":"https://stock-news.laohu8.com/highlight/detail?id=2582765339","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2582765339?lang=zh_cn&edition=full","pubTime":"2025-11-11 02:21","pubTimestamp":1762798883,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日02时21分，Cytosorbents Corporation股票出现波动，股价大幅上涨5.85%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.17%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。消息层面，截至02时21分，《Cytosorbents将于11月13日盘后发布财报，一图速览分析师最新预测》资讯为影响Cytosorbents Corporation的重要信息。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111022124a497d8a4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251111022124a497d8a4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2581096667","title":"Cytosorbents Corporation盘中异动 早盘股价大跌5.08%报0.751美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2581096667","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581096667?lang=zh_cn&edition=full","pubTime":"2025-11-06 00:22","pubTimestamp":1762359752,"startTime":"0","endTime":"0","summary":"北京时间2025年11月06日00时22分，Cytosorbents Corporation股票出现波动，股价快速下挫5.08%。截至发稿，该股报0.751美元/股，成交量4.0951万股，换手率0.07%，振幅2.53%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为1.94%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106002232a6e3a96b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251106002232a6e3a96b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"1100696270","title":"Cytosorbents计划下月向FDA提交预会议申请，正式会议预期在第四季度举行","url":"https://stock-news.laohu8.com/highlight/detail?id=1100696270","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100696270?lang=zh_cn&edition=full","pubTime":"2025-09-16 19:05","pubTimestamp":1758020738,"startTime":"0","endTime":"0","summary":"Cytosorbents计划下月向FDA提交预会议申请，正式会议预期在第四季度举行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2561427332","title":"Cytosorbents Corporation盘中异动 快速下跌6.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2561427332","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2561427332?lang=zh_cn&edition=full","pubTime":"2025-08-22 03:56","pubTimestamp":1755806215,"startTime":"0","endTime":"0","summary":"北京时间2025年08月22日03时56分，Cytosorbents Corporation股票出现波动，股价大幅跳水6.03%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.89%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082203565594f2eb19&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025082203565594f2eb19&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2558666950","title":"Cytosorbents Corporation盘中异动 大幅拉升5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2558666950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2558666950?lang=zh_cn&edition=full","pubTime":"2025-08-11 22:03","pubTimestamp":1754921028,"startTime":"0","endTime":"0","summary":"北京时间2025年08月11日22时03分，Cytosorbents Corporation股票出现波动，股价快速拉升5.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.20%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112203489740f025&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202508112203489740f025&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2557527785","title":"Cytosorbents Corporation盘中异动 大幅拉升5.17%报0.939美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2557527785","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2557527785?lang=zh_cn&edition=full","pubTime":"2025-08-08 21:32","pubTimestamp":1754659968,"startTime":"0","endTime":"0","summary":"北京时间2025年08月08日21时32分，Cytosorbents Corporation股票出现波动，股价快速拉升5.17%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.41%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213248a47d5b38&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250808213248a47d5b38&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2556181853","title":"Cytosorbents Corporation盘中异动 临近收盘股价大跌5.21%报0.872美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2556181853","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2556181853?lang=zh_cn&edition=full","pubTime":"2025-08-01 03:49","pubTimestamp":1753991367,"startTime":"0","endTime":"0","summary":"北京时间2025年08月01日03时49分，Cytosorbents Corporation股票出现波动，股价快速下挫5.21%。截至发稿，该股报0.872美元/股，成交量11.2527万股，换手率0.18%，振幅7.86%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为1.66%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801034927a6cc30f0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250801034927a6cc30f0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2555047260","title":"Cytosorbents Corporation盘中异动 股价大涨6.90%报0.973美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2555047260","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2555047260?lang=zh_cn&edition=full","pubTime":"2025-07-30 21:38","pubTimestamp":1753882682,"startTime":"0","endTime":"0","summary":"北京时间2025年07月30日21时38分，Cytosorbents Corporation股票出现波动，股价急速拉升6.90%。截至发稿，该股报0.973美元/股，成交量747股，换手率0.00%，振幅0.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.04%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213802a46bb6ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250730213802a46bb6ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2554777448","title":"Cytosorbents Corporation盘中异动 股价大涨6.98%报1.010美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2554777448","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554777448?lang=zh_cn&edition=full","pubTime":"2025-07-28 21:34","pubTimestamp":1753709692,"startTime":"0","endTime":"0","summary":"北京时间2025年07月28日21时34分，Cytosorbents Corporation股票出现异动，股价快速上涨6.98%。截至发稿，该股报1.010美元/股，成交量1651股，换手率0.00%，振幅0.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.22%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821345294bf6fc3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072821345294bf6fc3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2552436870","title":"Cytosorbents Corporation盘中异动 下午盘股价大涨5.77%报1.10美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2552436870","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2552436870?lang=zh_cn&edition=full","pubTime":"2025-07-18 01:52","pubTimestamp":1752774755,"startTime":"0","endTime":"0","summary":"北京时间2025年07月18日01时52分，Cytosorbents Corporation股票出现异动，股价大幅拉升5.77%。截至发稿，该股报1.10美元/股，成交量3.7839万股，换手率0.06%，振幅3.85%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为1.78%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071801523597aa0fa7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025071801523597aa0fa7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2550686699","title":"Cytosorbents Corporation盘中异动 股价大跌7.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2550686699","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550686699?lang=zh_cn&edition=full","pubTime":"2025-07-12 00:33","pubTimestamp":1752251637,"startTime":"0","endTime":"0","summary":"北京时间2025年07月12日00时33分，Cytosorbents Corporation股票出现波动，股价快速下挫7.02%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为1.55%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712003358953eff27&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250712003358953eff27&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2550653376","title":"Cytosorbents Corporation盘中异动 早盘急速拉升5.24%报1.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2550653376","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2550653376?lang=zh_cn&edition=full","pubTime":"2025-07-09 21:40","pubTimestamp":1752068417,"startTime":"0","endTime":"0","summary":"北京时间2025年07月09日21时40分，Cytosorbents Corporation股票出现波动，股价急速上涨5.24%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.06%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214018a69f8fdd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250709214018a69f8fdd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2549553915","title":"Cytosorbents Corporation盘中异动 早盘急速上涨6.33%报1.16美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2549553915","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2549553915?lang=zh_cn&edition=full","pubTime":"2025-07-07 21:33","pubTimestamp":1751895190,"startTime":"0","endTime":"0","summary":"北京时间2025年07月07日21时33分，Cytosorbents Corporation股票出现波动，股价大幅上涨6.33%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.31%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213310a69b1a36&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250707213310a69b1a36&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2548386413","title":"Cytosorbents Corporation盘中异动 临近午盘股价大涨5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2548386413","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548386413?lang=zh_cn&edition=full","pubTime":"2025-07-03 23:39","pubTimestamp":1751557177,"startTime":"0","endTime":"0","summary":"北京时间2025年07月03日23时39分，Cytosorbents Corporation股票出现波动，股价大幅拉升5.00%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.08%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。该公司的产品包括 Cytosorb、ECOS-300CY、VetResQ、HemoDefender 和 DrugSorb-ATR。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032339389798c7b5&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202507032339389798c7b5&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4082","CTSO"],"gpt_icon":0},{"id":"2548489017","title":"Cytosorbents Corporation股价重挫13.95% 市值跌969.5万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2548489017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2548489017?lang=zh_cn&edition=full","pubTime":"2025-07-02 21:31","pubTimestamp":1751463073,"startTime":"0","endTime":"0","summary":"北京时间2025年07月02日21时31分，Cytosorbents Corporation股票出现异动，股价大幅下跌13.95%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.08%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702213113a4cb52f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250702213113a4cb52f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2547709061","title":"Cytosorbents Corporation盘中异动 早盘快速拉升5.69%","url":"https://stock-news.laohu8.com/highlight/detail?id=2547709061","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2547709061?lang=zh_cn&edition=full","pubTime":"2025-06-30 21:31","pubTimestamp":1751290267,"startTime":"0","endTime":"0","summary":"北京时间2025年06月30日21时31分，Cytosorbents Corporation股票出现异动，股价快速上涨5.69%。Cytosorbents Corporation股票所在的医疗器械行业中，整体跌幅为0.18%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213107a4c6c3e2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250630213107a4c6c3e2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0},{"id":"2546246982","title":"Cytosorbents Corporation盘中异动 急速跳水5.83%报1.13美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546246982","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546246982?lang=zh_cn&edition=full","pubTime":"2025-06-25 21:41","pubTimestamp":1750858902,"startTime":"0","endTime":"0","summary":"北京时间2025年06月25日21时41分，Cytosorbents Corporation股票出现异动，股价急速下挫5.83%。Cytosorbents Corporation股票所在的医疗器械行业中，整体涨幅为0.06%。Cytosorbents Corporation公司简介：CytoSorbents Corp 专门使用专有的聚合物吸附技术治疗重症监护和心脏手术中危及生命的疾病。其旗舰产品 CytoSorb 在欧盟被批准作为体外细胞因子吸收剂，旨在减少炎症并预防败血症和创伤等危重疾病中的多器官衰竭。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214142978e8345&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625214142978e8345&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CTSO","BK4082"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cytosorbents.com","stockEarnings":[{"period":"1week","weight":-0.1347},{"period":"1month","weight":-0.0514},{"period":"3month","weight":-0.3113},{"period":"6month","weight":-0.4603},{"period":"1year","weight":-0.3801},{"period":"ytd","weight":-0.312}],"compareEarnings":[{"period":"1week","weight":-0.0042},{"period":"1month","weight":0.0131},{"period":"3month","weight":0.0314},{"period":"6month","weight":0.1394},{"period":"1year","weight":0.1266},{"period":"ytd","weight":0.1615}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cytosorbents Corporation于2002年4月25日在内华达州注册成立。该公司是重症监护运用血液净化调节炎症的集中免疫治疗公司，以预防或治疗危及生命的多器官衰竭为目标。该技术是基于生物相容的，高度多孔的聚合物吸附剂的珠子，其能够提取血液和其它体液中不需要的物质。该技术是受32项美国专利的保护。","yearOnYearQuotes":[{"month":1,"riseRate":0.545455,"avgChangeRate":0.086963},{"month":2,"riseRate":0.818182,"avgChangeRate":0.104089},{"month":3,"riseRate":0.272727,"avgChangeRate":-0.036736},{"month":4,"riseRate":0.545455,"avgChangeRate":-0.069534},{"month":5,"riseRate":0.363636,"avgChangeRate":0.018485},{"month":6,"riseRate":0.636364,"avgChangeRate":0.061167},{"month":7,"riseRate":0.727273,"avgChangeRate":0.072159},{"month":8,"riseRate":0.545455,"avgChangeRate":-0.031785},{"month":9,"riseRate":0.363636,"avgChangeRate":0.005522},{"month":10,"riseRate":0.181818,"avgChangeRate":-0.071309},{"month":11,"riseRate":0.363636,"avgChangeRate":-0.062459},{"month":12,"riseRate":0.181818,"avgChangeRate":-0.08768}],"exchange":"NASDAQ","name":"Cytosorbents Corporation","nameEN":"Cytosorbents"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cytosorbents Corporation(CTSO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cytosorbents Corporation,CTSO,Cytosorbents Corporation股票,Cytosorbents Corporation股票老虎,Cytosorbents Corporation股票老虎国际,Cytosorbents Corporation行情,Cytosorbents Corporation股票行情,Cytosorbents Corporation股价,Cytosorbents Corporation股市,Cytosorbents Corporation股票价格,Cytosorbents Corporation股票交易,Cytosorbents Corporation股票购买,Cytosorbents Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cytosorbents Corporation(CTSO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cytosorbents Corporation(CTSO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}